0001792612-23-000001.txt : 20230616 0001792612-23-000001.hdr.sgml : 20230616 20230616134142 ACCESSION NUMBER: 0001792612-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 EFFECTIVENESS DATE: 20230616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avenzoar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001792612 IRS NUMBER: 475352251 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-484484 FILM NUMBER: 231020233 BUSINESS ADDRESS: STREET 1: 662 ENCINITAS BLVD., SUITE 248 CITY: ENCINITAS STATE: CA ZIP: 92024 BUSINESS PHONE: (310) 502-0770 MAIL ADDRESS: STREET 1: 662 ENCINITAS BLVD., SUITE 248 CITY: ENCINITAS STATE: CA ZIP: 92024 D 1 primary_doc.xml X0708 D LIVE 0001792612 Avenzoar Pharmaceuticals, Inc. 1819 Outpost Dr. Los Angeles CA CALIFORNIA 90089 (310) 502-0770 CALIFORNIA None None Corporation true Terrance J. Bruggeman 1819 Outpost Dr. Los Angeles CA CALIFORNIA 90089 Executive Officer Director Mouad Edderkaoui 1819 Outpost Dr. Los Angeles CA CALIFORNIA 90089 Director Stephen Pandol 1819 Outpost Dr. Los Angeles CA CALIFORNIA 90089 Director Mark Chin 1819 Outpost Dr. Los Angeles CA CALIFORNIA 90089 Director Shierley Widjaja 1819 Outpost Dr. Los Angeles CA CALIFORNIA 90089 Director Biotechnology Decline to Disclose 06b false 2023-05-31 true true true false 0 2970000 899748 2070252 false 2 0 0 79748 false Avenzoar Pharmaceuticals, Inc. Terrance J. Bruggeman Terrance J. Bruggeman Chief Executive Officer 2023-06-16